نمایش مختصر رکورد

dc.contributor.authorPARLAR, Alien_US
dc.contributor.authorARSLAN, Seyfullahen_US
dc.date.accessioned1399-07-09T06:55:57Zfa_IR
dc.date.accessioned2020-09-30T06:55:57Z
dc.date.available1399-07-09T06:55:57Zfa_IR
dc.date.available2020-09-30T06:55:57Z
dc.date.issued2020-02-01en_US
dc.date.issued1398-11-12fa_IR
dc.date.submitted2019-01-13en_US
dc.date.submitted1397-10-23fa_IR
dc.identifier.citationPARLAR, Ali, ARSLAN, Seyfullah. (2020). CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats. Iranian Journal of Pharmaceutical Research, 19(1), 3-17. doi: 10.22037/ijpr.2020.15456.13104en_US
dc.identifier.issn1735-0328
dc.identifier.issn1726-6890
dc.identifier.urihttps://dx.doi.org/10.22037/ijpr.2020.15456.13104
dc.identifier.urihttp://ijpr.sbmu.ac.ir/article_1100998.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/312254
dc.description.abstractAsthma is a disease characterized by spontaneous contraction of the airways in response to a wide variety of endogenous and exogenous stimuli. Many asthma models are used to mimic the human asthma model in the literature. In order to better understand the role of the cannabinoid (CB) 2 receptor in the ovalbumin (OVA)-induced asthma model, a combination of both selective CB2 agonist (AM1241) and antagonist (AM630) was used to improve inflammatory hypersensitivity and edema in rats. In the present study, it was found that OVA decreased body weight (pen_US
dc.format.extent1700
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherSchool of Pharmacy, Shahid Beheshti University of Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Pharmaceutical Researchen_US
dc.relation.isversionofhttps://dx.doi.org/10.22037/ijpr.2020.15456.13104
dc.subjectCB2 receptoren_US
dc.subjectOvalbuminen_US
dc.subjectAsthmaen_US
dc.subjectCB2 agonisten_US
dc.subjectAM1241en_US
dc.subjecttoxicology and Pharmacologyen_US
dc.titleCB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Ratsen_US
dc.typeTexten_US
dc.typeResearch articleen_US
dc.contributor.departmentUniversity of Adiyaman, Faculty of Medicine, Department of Pharmacology, Adiyaman, Turkey.en_US
dc.contributor.departmentPharmacology Department, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.en_US
dc.citation.volume19
dc.citation.issue1
dc.citation.spage3
dc.citation.epage17
nlai.contributor.orcid0000-0002-4656-3402


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد